Feedback plc (FDBK) ORD GBP0.5
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
Feedback inks collaboration deal with Vertex In Healthcare
10 July 2024 14:24
(Sharecast News) - Clinical infrastructure specialist Feedback announced a collaboration agreement with Vertex In Healthcare, a clinical IT firm with a presence in the UK, the UAE, and South Africa, on...
-
Feedback secures contract with Queen Victoria Hospital
1 July 2024 09:09
(Sharecast News) - Clinical infrastructure business Feedback has scored a contract with the Queen Victoria Hospital to provide its Bleepa Community Diagnostics Centre solution.
-
Feedback FY revenues seen higher despite NHS contract delays
22 May 2024 10:55
(Sharecast News) - Clinical infrastructure specialist Feedback said on Wednesday that full-year revenues were seen higher and that underlying losses had narrowed but warned that certain NHS procurement...
-
Feedback secures funding for Oldham pilot
21 March 2024 16:21
(Sharecast News) - Feedback has secured £50,000 in funding to initiate a Community Diagnostic Centre (CDC) pathway pilot with the Oldham CDC, it announced on Thursday, managed by the Northern Care Alliance.
-
Feedback inks fresh deal with Medical Imaging Partnership
21 February 2024 13:15
(Sharecast News) - Feedback announced a significant development in its clinical infrastructure offerings on Wednesday, with radiology specialist Medical Imaging Partnership (MIP) agreeing to pilot...
-
Feedback ends busy year on a high
19 June 2023 11:31
(Sharecast News) - Clinical technology company Feedback released a positive trading update for the 12 months ended 31 May on Monday.
-
Feedback H1 revenues seen 200% higher YOY
19 December 2022 09:21
(Sharecast News) - Medical technology company Feedback said on Monday that revenues had risen roughly 200% in the six months ended 30 November as the group traded in line with internal and external...
-
Feedback FY revenues more than double
16 June 2022 09:07
(Sharecast News) - Clinical communication company Feedback said on Thursday that full-year trading was "materially ahead of market expectations", with revenues expected to be roughly 105% higher...
-
Feedback awarded two year-long NHS contracts
12 April 2022 13:22
(Sharecast News) - Clinical communications specialist Feedback has been awarded two 12-month contracts to provide its flagship product 'Bleepa' across two NHS trusts, it announced on Friday, for a...
-
Feedback enters deal for NHS care system pilot
19 October 2021 15:20
(Sharecast News) - Clinical communications company Feedback has entered into a memorandum of understanding for a pilot scheme to provide community diagnostic centre (CDC) services with Sussex Integrated Care...
Company announcements Announcements
-
Vertex In Healthcare Collaboration
10 July 2024 07:00
Feedback
-
CDC Contract Awarded by Queen Victoria Hospital
1 July 2024 07:00
Feedback
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.